The 2019 balance sheet of Side Effect Pharmaceutical shows average shareholders' equity of $9,996 million, net operating profit after-tax of $2,308 million, net income of $2,513 million, and common shares issued of 950,044 million. Side Effect has not issued any preferred shares. Side Effect's return on equity (ROE) for 2019 is?

The 2019 financial statements of Broken Pipeline, Inc. reveal average shareholders' equity of $837,283 thousand, net operating profit after tax of $48,032 thousand, net income of $29,068 thousand, and average net operating assets of $354,414 thousand.

Broken Pipeline's return on equity (ROE) for the year is?

Answer rating: 100% (QA)

To calculate the return on equity ROE you need to divide t... View the full answer